Dallas children's hospital relocates patients after finding mold

Children's Medical Center Dallas relocated 28 patients after routine air tests


Children's Medical Center Dallas recently relocated 28 patients after routine air tests showed higher-than-normal levels of Aspergillus and Penicillium molds, according to an article on the CNN website.

The patients were moved from the cardiac intensive care unit at Children's Medical Center Dallas to other parts of the facility.

No patients have become infected and none have experienced any health effects as a result of the mold, the hospital said.

No previous tests at the hospital showed mold outside the expected ranges, according to a spokesperson. There is an ongoing investigation into last week's test results.

Read the article.



December 17, 2019


Topic Area: Infection Control


Recent Posts

What Lies Ahead for Healthcare Facilities Managers

Staffing shortages, rising regulatory scrutiny and accelerating adoption of AI are converging to reshape the way healthcare facilities are managed.


What's in the Future for Healthcare Restrooms?

Workforce shortages, rising hygiene expectations and connected technologies are pushing healthcare restrooms beyond basic utility.


Hammes Completes the Moffit Speros Outpatient Center

The new outpatient center will provide infusion services, clinical space, radiology and radiation oncology.


The Top Three Pathogens to Worry About in 2026

Key viruses to watch out for and how to prevent them.


Blackbird Health Opens New Pediatric Mental Health Clinic in Virginia

It offers comprehensive evaluations, therapy and medication management under one roof.


 
 


FREE Newsletter Signup Form

News & Updates | Webcast Alerts
Building Technologies | & More!

 
 
 


All fields are required. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 
 
 
 

Healthcare Facilities Today membership includes free email newsletters from our facility-industry brands.

Facebook   Twitter   LinkedIn   Posts

Copyright © 2023 TradePress. All rights reserved.